CLINICAL_TRIALS
trial_result
· 2019-04-08
Clinical Trial Update: Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects [Phase 1]
Summary
Phase 1 pharmacokinetic study of lurasidone after multiple oral administrations in healthy subjects; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2019-04-08